Friday, September 27, 2013

The Dark Side of Antioxidants

Note: This story, which I wrote back in April 2013, originally appeared in a slightly shorter form at I'm reproducing it here because I strongly feel the story needs to get out to as many people as possible.

The story of the dark side of antioxidant research isn't well known outside of medical circles. It's an unseemly story, profoundly unsettling; a story that refuses to be made pretty or happy or uplifting no matter how hard you try to duct-tape a silver lining around it. It doesn't fit the "antioxidants are good for you" mantra that sells billions of dollars per year of blueberry- and pomegranate-fortified granola bars and tocopherol-enrichened cereals, acai-berry Jell-O mixes, juices and yogurts with added vitamins, organic baby foods, and so forth, not to mention the billions of dollars of nutritional supplements sold each year (to say nothing of the sub-industry of books and magazines devoted to nutrition).

Still, it's a story that needs to be told. And some of us know where the bodies are buried.

For decades, mainstream medicine pooh-poohed the possibility that vitamins or supplements could "move the needle" on major diseases. Two-time Nobel laureate Linus Pauling was harshly criticized in the 1970s and 80s for suggesting a role for Vitamin C in prevention and treatment of cancer. Even so, laboratory workers had known for years that changes to diet could influence the rate of tumor appearance in lab animals. By the early 1980s, case-control studies and epidemiological evidence from a variety of sources had begun to accumulate, showing that persons who routinely ate large quantities of fresh fruits and vegetables consistently did better with regard to cardiovascular disease (and other diseases) than most people.

In 1981, Sir Richard Peto and colleagues published a paper in Nature that dared asked the simple question: "Can dietary beta-carotene materially reduce human cancer rates?" (Nature, 290:201-208) Shortly thereafter, the National Cancer Institute (whose Chemoprevention branch was headed by Dr. Michael B. Sporn, one of the coauthors of the Nature article) decided to green-light two large intervention-based studies of the cancer-preventing effects of nutritional supplements: a study in Finland involving beta-carotene and alpha-tocopherol (Vitamin E), and a U.S.-based study involving retinol (a form of Vitamin A) and beta-carotene.

The Finnish study (conducted by Finland's National Institute for Health and Welfare) was initially designed to encompass 18,000 male smokers between the ages of 50 and 69. Why just smokers? And why male, and 50+ years old? Lung cancer is ten times more likely to affect smokers; hence a cancer study limited to smokers would need only a tenth as many participants as a study involving the general population. Based on what was known about the age-specific rates of lung cancer among Finnish men, study designers calculated that the desired effect size (a hoped-for 25% decrease in cancer incidence over a period of 6 years) would be measurable with the required level of statistical relevance if 18,000 older male smokers made up the study group. As it turned out, the age distribution of actual volunteers didn't match the demographics of the eligibility group (volunteers tended to be toward the young end of the eligibility range), and as a result the study's enrollment target had to be reset to 27,000 in order to get good statistical relevance.

Full-scale recruitment of subjects into the ATBC (Alpha-Tocopherol Beta-Carotene) Lung Cancer Prevention Study began in April 1985 and continued until a final enrollment of 29,246 men occurred in June 1988. Enrollees were randomized into one of four equal-sized groups, receiving either 50 mg/day (about 6 times the RDA) of alpha-tocopherol, or 20 mg/day of beta-carotene (equivalent to around 3 times the RDA of Vitamin A), or AT and BT together, or placebo only.

At the same time, which is to say starting in 1985 (after some very small, very brief pilot studies to validate recruitment mechanics), the Carotene and Retinol Efficacy Trial (CARET) started enrolling volunteers in the U.S. Unlike Finland's ATBC study, volunteers for CARET were both male and female and were heavy smokers or came from asbestos-exposed workplace environments. They ranged in age from 45 to 69 and were divided initially into four groups (30 mg/day beta carotene only, 25,000 IU retinol-only, carotene plus retinol, or placebo), but in 1988 the treatment groups were consolidated into one group taking both beta-carotene and retinol. The study design called for continuing the vitamin regimen through 1997, with reporting of results to occur in 1998.

Alas, things went horribly awry, and CARET never got that far.

When the Finns reported results from the ATBC study in April 1994, it sent shock waves through the medical world. Not only had alpha-tocopherol and beta-carotene not provided the expected protective effect against lung cancer; the supplement-treated groups actually experienced more cancer than the placebo group—18% more, in fact. 

This was an astonishing result, utterly bewildering, as it contradicted numerous prior animal studies that had shown Vitamin E and beta-carotene to be promising cancer preventatives. Surely an error had occurred. Something had to have gone wrong. One thing it couldn't be was chance variation: with almost 30,000 participants (three quarters of them in treatment groups), this was not a small study. The results couldn't be a statistical fluke.

As it turns out, the Finnish investigators had actually done a meticulous job from start to finish. In analyzing their data, they had looked for possible confounding factors. The only confounder they found was that heavy drinkers in the treatment group got cancer more often than light drinkers.

Two weeks before the Finnish study hit, the National Cancer Institute was awash in conference calls. Accounts vary as to who knew what, when, but CARET's lead investigator, who had seen the Finnish group's data prior to publication, knew that NCI now had a serious problem on its hands. CARET was doing essentially the same experiment the Finns had done, except it was giving even bigger doses of supplements to its U.S. participants, and the study was due to run for another three and a half years. What if CARET's treatment group was also experiencing elevated cancer rates? Participants might be dying needlessly.

And indeed they were.

When statisticians presented interim results to CARET's Safety Endpoint Monitoring Committee in August 1994, four months after the Finnish study appeared in print, it became clear that CARET participants were, if anything, faring considerably worse than their counterparts in the ATBC study. Even so, the safety committee found itself deadlocked on whether to call a premature halt to CARET. The study's formal stopping criteria (as given by something called the O’Brien–Fleming early-stopping boundary) had not been met. Ultimately a decision was made to continue to accumulate more data. There were those on the safety committee who simply didn't believe the results. The data were aberrant; they had to be. When additional numbers could be gathered they would surely show the early numbers to have been wrong.

A second interim statistical analysis was presented to CARET's safety committee in September 1995, one year after the first analysis. According to the committee:
At that time it was clear that the excess of lung cancer had continued to accumulate in the intervention regimen at about the same rate during the time since the first interim analysis. Further, the cardiovascular disease excess persisted. The conditional power calculations showed that it was extremely unlikely that the trial could show a beneficial effect of the intervention, even if the adverse effect ceased to occur and a delayed protective effect began to appear. Therefore the SEMC voted unanimously to recommend to NCI that the trial regimen should be stopped but the follow-up should continue.
The study was halted—but not until January 1996, nearly two years after final publication of the Finnish results. (Even then, CARET participants were contacted by snail mail to let them know of the study's early termination and the reasons for it.)

CARET's results were published in The New England Journal of Medicine in May 1996. Once again, shock waves reverberated throughout the medical world. Participants who had taken beta-carotene and Vitamin A supplements had shown a 28% higher rate of lung cancer. They also fared 26% worse for cardiovascular-related mortality, and 17% worse for all-cause mortality.

There was great reluctance in the medical community to believe the results. Perhaps the even-worse results of the CARET study (relative to the Finnish experiment) had to do with the decision to include 2,044 asbestos-exposed individuals in the treatment group of 9,241 persons? Not so, it turns out. Intensive segment analysis of the asbestos group's data relative to the heavy-smoker group showed that "There was no statistical evidence of heterogeneity of the relative risk among these subgroups."

What the CARET study had, in fact, done was not just replicate the ATBC results but provide the beginnings of a dose-response curve. The Finns had used 20 mg/day of beta-carotene; CARET employed a 50% higher dose. The result had been 50% more cancer.

It was hard to understand the results of the ATBC and CARET studies in light of the fact that another large trial involving beta-carotene, the Physicians' Health Study, had reported neither harm nor benefit from 50 mg of beta carotene taken every other day for 12 years. However, the Physicians' Health Study population was younger and healthier than ATBC or CARET study groups and was predominantly (89%) made up of non-smokers. This turned out to be quite important. (Read on.)

It's been almost 20 years since the ATBC and CARET results were reported. (And to this day, most clinicians are not aware of the results of either study, at least in the U.S.) What have we learned in that time?

In 2007, Bjelakovic et al. undertook a systematic review of existing literature on antioxidant studies covering the time frame 1977 to 2006. The systematic review procedure was conducted using the well-regarded methodology of the Cochrane Collaboration, a group that specializes in (and is known for) high-quality meta-analyses. In analyzing the 47 most rigorously designed studies of supplement effectiveness, Bjelakovic et al. found that 15,366 study subjects (out of a total treatment population of 99,095 persons) died while taking antioxidants, whereas 9,131 placebo-takers, in control groups totalling 81,843 persons, died in those same studies. (This is not including ATBC or CARET results.) The studies in question used beta-carotene, Vitamin E, Vitamin A, Vitamin C, and/or selenium.

In a separate meta-analysis, Miller et al. found a dose-dependent relationship of Vitamin E with all-cause mortality for 135,967 participants in 19 clinical trials. At daily doses below about 150 International Units, Vitamin E appears to be helpful; above that, harmful. Miller et al. concluded:
In view of the increased mortality associated with high dosages of beta -carotene and now vitamin E, use of any high-dosage vitamin supplements should be discouraged until evidence of efficacy is documented from appropriately designed clinical trials.
How are we to make sense of these results? Why have so many studies shown a harmful effect for antioxidants when so many other studies (particularly those carried out in animals, but also those carried out in predominantly healthy human populations) have shown a clear benefit?

The answer may have to do with something called apoptosis, otherwise known as programmed cell death. The body has ways of determining when cells have become dysfunctional to the point of needing to be told to shut down. When cells reach this point, their mitochondria kick off a cascade of reactions (involving caspases and other enzymes) designed to terminate the cells. Most cancer therapies exert their effect by inducing apoptosis, and it's fairly well accepted that in normal, healthy individuals, precancerous cells are constantly being formed, then destroyed through apoptosis. (In a normal healthy adult, as many as 50 billion cells a day, most of them non-cancerous, are destroyed this way.) Antioxidants are known to interfere with apoptosis. In essence, they promote the survival of normal cells as well as cells that shouldn't be allowed to live.

If you're a young non-smoker in good health, the level of cell turnover (from apoptosis) in your body is nowhere near as high as the level of turnover in an older person, or someone at high risk of cancer. Therefore, antioxidants are apt to do more good than harm in a young, healthy person. But if your body is harboring cancer cells, you don't want anitoxidants to encourage the growth of neoplastic cells by interfering with their apoptosis. This is the real lesson of antioxidant research.

The food industry and the people who make nutritional supplements have no interest in telling you any of the things you've read here. But now that you know the story of the dark side of antioxidants (a story made possible by thousands of ordinary people who died in the name of science), you owe it to yourself to take the story to heart. If you're a smoker or at high risk for heart disease or cancer, consider scaling back your use of lipid-soluble antioxidant supplements (particularly vitamins A and E); it could save your life. (There is no need to scale back vitamin D, however, which has potent anti-cancer effects.) And please, if you found any of this information helpful, share it with family, friends, Facebook and Twitter followers, and others. The story needs to get out. The cancer industry isn't going to tell it to you. They haven't so far. There's too much money to be made selling you $70,000-a-year chemotherapies. No one's going to look out for your health but you.

You Might Also Like
Aspirin for cancer prevention (at An enormous body of evidence points to vast reductions in cancer rates, for a wide variety of cancers, for those who take NSAIDs like iburofen and aspirin daily.

When Vitamins Turn Deadly: More on the CARET disaster and why it took so long to terminate the study when investigators knew full well that people were dying unnecessarily.

Who Needs Antioxidants? Why the free-radical theory of aging is just plain wrong.


  1. Anonymous6:51 PM

    All you are really showing here is design of the study is flawed. Nothing else in these people lifestyles changed. Why did they only pick smokers? Is it because smokers are more likely to get lung cancer? Has anyone conducted studies where they got smokers to stop smoking and then measured the rates of the occurrence of lung cancer?

    If antioxidants are really bad for you, how is it that certain diseases are cured by antioxidants, e.g. scurvy and rickets. Has anyone done a study there they removed all antioxidants from peoples diets and measured their increase in overall health?


  2. Nice Blog!!!!!!

    Read my all blog care fully you will get definetly great ideas from here

    Chiropractic Clinic Singapore
    Back pain Treatment Singapore
    Singapore Chiropractor
    Chiropractic Singapore
    Gonstead chiropractic Singapore

    Nice Post!!!
    If you are problem with neck pain and shoulder pain Singapore, then you are not alone, as we see a lot of people in our chiropractic centers with these problems. And they all are satisfied with our treatment, so join with for neck pain treatment Singapore

    Best Chiropractor Singapore
    Back pain Treatment Singapore
    Shoulder Pain Specialist Singapore
    Best Chiropractor Singapore

  3. Nice one !!

    We have love doll that is a Sorority blonde bombshell with the trappings of a classic American beauty. This pure blonde is a rarity and her pink taco is ready for a good pounding. After all, gentlemen do prefer blondes so pick up this sexy blonde realistic sex dolls today and have some fun!

  4. We are the best writing company providing Write My Nursing Research Paper Services of the highest quality. Our articles are appropriately formatted and referenced Nursing Research Paper Writing Services under institutional or professor’s guidelines.

  5. Nice Post! The increasing importance of Writing Assignments has prompted students to take a helping hand from Information Technology Assignment Help


  6. شركة سكاي لخدمات نقل العفش والاثاث بالمنطقة العربية السعودية نحن نوفر خدمات نقل اثاث بالرياض ونقل عفش بالمدينة المنورة ونقل عفش بمكة ونقل عفش بالطائف نحن نقدم افضل نقل اثاث بخميس مشيط ونقل عفش بجدة
    شركة سكاي نقل العفش
    مدونة لنقل العفش
    شركة نقل عفش بمكة
    شركة نقل عفش بالرياض
    شركة نقل عفش بالمدينة المنورة
    شركة نقل عفش بجدة
    شركة نقل عفش بالطائف


  7. My travel life have been easier with Garmin Express. Plus I can get all the additional knowledge through their blogs. I use the Garmin app and is totally upto the mark. I recommend everyone to use Garmin Map Update and get Garmin life time map update or call +1-888-309-0939 for instant help from Garmin GPS experts.

  8. I did not know the entire benefits of Garmin Nuvi Update. But since I have read this blog on map update, I have installed all available updates for my garmin device. I must say that this piece of blog has helped me improve navigation experience. I am not suggesting all my friends to read this blog and get with this team. For detailed information, you can contact us at toll-free number +1 888-309-0939. Our Garmin GPS professionals will provide instant help.

  9. Great post keep up the good work. Thank for share amazing blog..
    Assignment Writing Help


  10. Thanks for your content…Please visit my site!
    Law Assignment Help UK


Add a comment. Registration required because trolls.